DNAStar Awarded NIH SBIR Grant for Clinical NGS Analysis Software | GenomeWeb

DNAStar said this week that that it has received a fast-track Phase I and Phase II Small Business
Innovation award from the National Institutes of Health to support the development of sequence analysis software for the clinical research market.

Tom Schwei, vice president and general manager of DNAStar, said in a statement that the funding "will be used to accelerate the speed with which we can move from the general research market into the clinical research market."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.